Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Pool Corp
POOL
US OptionsDetailed Quotes
PGR250509C277500
- 5.13
- -1.45-22.04%
15min DelayTrading May 5 09:54 ET
5.14High5.12Low
5.12Open6.58Pre Close3 Volume26 Open Interest277.50Strike Price1.54KTurnover30.03%IV-0.03%PremiumMay 9, 2025Expiry Date5.20Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.7413Delta0.0355Gamma39.82Leverage Ratio-0.3878Theta0.0234Rho29.51Eff Leverage0.0983Vega
Progressive Newsroom
Progressive | 10-Q: Quarterly report
Earnings Preview: Progressive to Report Financial Results on May 05
30 U.S. Picks Based on Up Vs. Down EPS Revisions and Dividend Payouts
Promising Phase 2 Results for Vidofludimus Calcium in Progressive Multiple Sclerosis Highlight Potential for Neuroprotection and Disease Modification
Berkshire's Annual Meeting Is Coming. 10 Tough Questions for Warren Buffett
Hoya: Set Progressive Dividend Policy With Target Payout Ratio of 40%
Immunic's Vidofludimus Calcium Shows Promise in Treating Progressive MS: Analyst Upgrades to Buy
Express News | Mexico's Pemex Says Olmeca Refinery Is Currently in the Progressive Start-up Phase for the Reestablishment of Operations
Progressive Price Target Raised to $316 From $312 at BofA
Immunic Reports Data From Phase 2 CALLIPER Trial Of Nurr1 Activator, Vidofludimus Calcium, In Patients With Progressive Multiple Sclerosis
Express News | Eqs-News: Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients From Phase 2 Calliper Trial
Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients From Phase 2 CALLIPER Trial
Gedeon Richter: Medical Treatment of Endometriosis With a Progressive Approach
Morgan Stanley Maintains Progressive(PGR.US) With Buy Rating, Raises Target Price to $320
21 Analysts Assess Progressive: What You Need To Know
Progressive Shares Are Trading Higher After Morgan Stanley Raised Its Price Target on the Stock From $310 to $320 and Maintained an Overweight Rating.
Progressive's Pain May Turn To Gain As Tariff Inflation Creates A Surprising Tailwind
Progressive Corp Insider Sold Shares Worth $2,685,900, According to a Recent SEC Filing
Progressive Is Maintained at Overweight by Morgan Stanley
Progressive Analyst Ratings
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
